MITech Co Ltd
KOSDAQ:179290
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
MITech Co Ltd
Change in Working Capital
MITech Co Ltd
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
MITech Co Ltd
KOSDAQ:179290
|
Change in Working Capital
-₩2.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Change in Working Capital
-₩12.9B
|
CAGR 3-Years
31%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-7%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Change in Working Capital
-₩21.8B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Change in Working Capital
-₩27.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Change in Working Capital
-₩7.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-223%
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Change in Working Capital
-₩3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MITech Co Ltd
Glance View
M.I.Tech Co., Ltd. develops and manufactures non-vascular stent system. The company is headquartered in Pyeongtaek, Gyeonggi-Do and currently employs 157 full-time employees. The company went IPO on 2018-11-29. is a Korea-based company mainly engaged in the manufacturing and sale of stents. Stents include biliary, esophagus, pyloric, large intestine, duodenal stents, and stents for sample and study, among others. The Company’s stents are sold under the brand names of CHOOSTENT and HANAROSTENT. In addition, the Company is engaged in the manufacture and sale of low frequency therapies, crushers and blood glucose meters. The firm distributes its products within the domestic market and to overseas markets.
See Also
What is MITech Co Ltd's Change in Working Capital?
Change in Working Capital
-2.8B
KRW
Based on the financial report for Sep 30, 2025, MITech Co Ltd's Change in Working Capital amounts to -2.8B KRW.
What is MITech Co Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-1%
Over the last year, the Change in Working Capital growth was 24%. The average annual Change in Working Capital growth rates for MITech Co Ltd have been 23% over the past three years , -1% over the past five years .
